199 related articles for article (PubMed ID: 36460986)
1. Hemoperfusion and intravenous immunoglobulins for refractory gastrointestinal involvement in pediatric Henoch-Schönlein purpura: a single-center retrospective cohort study.
Zhang X; Che R; Xu H; Ding G; Zhao F; Huang S; Zhang A
BMC Pediatr; 2022 Dec; 22(1):692. PubMed ID: 36460986
[TBL] [Abstract][Full Text] [Related]
2. Changes of inflammatory mediators and oxidative stress indicators in children with Henoch-Schönlein purpura and clinical effects of hemoperfusion in the treatment of severe Henoch-Schönlein purpura with gastrointestinal involvement in children.
Zhu Y; Dong Y; Wu L; Deng F
BMC Pediatr; 2019 Nov; 19(1):409. PubMed ID: 31684904
[TBL] [Abstract][Full Text] [Related]
3. Age Related Characteristics Of Children And Adolescent With Henoch Schönlein Purpura And Systems Involvement: An Experience From Tertiary Care Center.
Aziz DA; Siddiqui F; Siddiqui MT
J Ayub Med Coll Abbottabad; 2022; 34(2):336-340. PubMed ID: 35576298
[TBL] [Abstract][Full Text] [Related]
4. Clinical outcome in pediatric refractory gastrointestinal Henoch-Schönlein purpura treated with mycophenolate mofetil.
Wang H; Zhang B; Li S; Ou R; Liu Y; Tan W
Eur J Pediatr; 2020 Sep; 179(9):1361-1366. PubMed ID: 32144502
[TBL] [Abstract][Full Text] [Related]
5. Intravenous immunoglobulins for severe gastrointestinal involvement in pediatric Henoch-Schönlein purpura: A French retrospective study.
Cherqaoui B; Chausset A; Stephan JL; Merlin E
Arch Pediatr; 2016 Jun; 23(6):584-90. PubMed ID: 27133370
[TBL] [Abstract][Full Text] [Related]
6. Analysis on kidney injury-related clinical risk factors and evaluation on the therapeutic effects of hemoperfusion in children with Henoch-Schonlein purpura.
Ma DQ; Li Y; Han ZG; Zheng M; Xu N; Fan XJ
Eur Rev Med Pharmacol Sci; 2017 Oct; 21(17):3894-3899. PubMed ID: 28975974
[TBL] [Abstract][Full Text] [Related]
7. Rituximab treatment for chronic steroid-dependent Henoch-Schonlein purpura: 8 cases and a review of the literature.
Crayne CB; Eloseily E; Mannion ML; Azerf SP; Weiser P; Beukelman T; Stoll ML; Feig DI; Prescott Atkinson T; Cron RQ
Pediatr Rheumatol Online J; 2018 Nov; 16(1):71. PubMed ID: 30428889
[TBL] [Abstract][Full Text] [Related]
8. Plasma exchange therapy for severe gastrointestinal involvement of Henoch Schönlein purpura in children.
Başaran Ö; Cakar N; Uncu N; Çelikel BA; Kara A; Cayci FS; Taktak A; Gür G
Clin Exp Rheumatol; 2015; 33(2 Suppl 89):S-176-80. PubMed ID: 25436762
[TBL] [Abstract][Full Text] [Related]
9. Construction and internal validation of a predictive model for risk of gastrointestinal bleeding in children with abdominal Henoch-Schönlein purpura: A single-center retrospective case-control study.
Sun L; Liu W; Li C; Zhang Y; Shi Y
Front Immunol; 2022; 13():1025335. PubMed ID: 36248897
[TBL] [Abstract][Full Text] [Related]
10. Effects of hemoperfusion in the treatment of childhood Henoch-Schönlein purpura nephritis.
Chen L; Wang Z; Zhai S; Zhang H; Lu J; Chen X
Int J Artif Organs; 2013 Jul; 36(7):489-97. PubMed ID: 23661557
[TBL] [Abstract][Full Text] [Related]
11. Necessity and choice of therapy for Henoch-Schönlein purpura nephritis.
Kurokawa M; Maehara K; Kaku Y; Honjo S
Pediatr Int; 2022 Jan; 64(1):e15282. PubMed ID: 36134650
[TBL] [Abstract][Full Text] [Related]
12. Do practical laboratory indices predict the outcomes of children with Henoch-Schönlein purpura?
Ekinci RMK; Balci S; Sari Gokay S; Yilmaz HL; Dogruel D; Altintas DU; Yilmaz M
Postgrad Med; 2019 May; 131(4):295-298. PubMed ID: 31021301
[No Abstract] [Full Text] [Related]
13. Analysis of children with Henoch-Schonlein purpura secondary to infection.
Liu C; Luo L; Fu M; Li Z; Liu J
Clin Rheumatol; 2022 Mar; 41(3):803-810. PubMed ID: 34993728
[TBL] [Abstract][Full Text] [Related]
14. [Clinical Significance of Serum Midkine in Children with Henoch-Schonlein Purpura].
Li MM; Liu N; Zhagn M; Xue HR
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Feb; 25(1):181-185. PubMed ID: 28245398
[TBL] [Abstract][Full Text] [Related]
15. Clinical analysis of 99 children with Henoch-Schönlein purpura complicated with overt gastrointestinal bleeding.
Yang Y; Shu J; Mu J; He Q; Chen F; Hu Y; Zhen X
Clin Rheumatol; 2022 Dec; 41(12):3783-3790. PubMed ID: 35941339
[TBL] [Abstract][Full Text] [Related]
16. Characteristics of immune function in the acute phase of Henoch-Schönlein purpura.
Ding Y; Zhou Y; Li HR; Xiong YH; Yin W; Zhao L
Clin Rheumatol; 2021 Sep; 40(9):3711-3716. PubMed ID: 33782751
[TBL] [Abstract][Full Text] [Related]
17. Neutrophil-to-lymphocyte Ratio: A Biomarker for Predicting Systemic Involvement in Henoch-Schonlein Purpura.
Lei W; Yun-Yun S; Ai-E X
Indian J Dermatol Venereol Leprol; 2021; 88(1):132. PubMed ID: 34623056
[TBL] [Abstract][Full Text] [Related]
18. Risk factors for renal involvement in Henoch-Schönlein purpura.
Kim WK; Kim CJ; Yang EM
J Pediatr (Rio J); 2021; 97(6):646-650. PubMed ID: 33722533
[TBL] [Abstract][Full Text] [Related]
19. Clinical manifestations and outcomes of 420 children with Henoch Schönlein Purpura from a single referral center from Turkey: A three-year experience.
Ekinci RMK; Balci S; Melek E; Karabay Bayazit A; Dogruel D; Altintas DU; Yilmaz M
Mod Rheumatol; 2020 Nov; 30(6):1039-1046. PubMed ID: 31662011
[No Abstract] [Full Text] [Related]
20. [Clinical effect and mechanism of hemoperfusion in treatment of children with severe abdominal Henoch-Schönlein purpura].
Zhu Y; Dong Y; Xu DL; Jiang JY; Wu L; Ke RJ; Fang SH; Peng Y
Zhongguo Dang Dai Er Ke Za Zhi; 2018 May; 20(5):378-382. PubMed ID: 29764574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
